https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-16 / Eur J Cancer 2021 Oct;158:123-132
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-16 / Eur J Cancer 2021 Oct;158:123-1322021-10-16 00:00:002021-10-16 00:00:00Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-14 / Biomedicines 2021 Oct;9(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-14 / Biomedicines 2021 Oct;9(10)2021-10-14 00:00:002021-10-14 00:00:00Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-09 / Life Sci 2021 Dec;286:120043
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-09 / Life Sci 2021 Dec;286:1200432021-10-09 00:00:002023-01-31 16:07:46Curcuma as an adjuvant in colorectal cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-05 / Front Immunol 2021;12:721830
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-05 / Front Immunol 2021;12:7218302021-10-05 00:00:002022-01-10 09:06:12Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-742021-10-04 00:00:002023-05-30 16:42:19Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-09-23 / Front Oncol 2021;11:730824
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-09-23 / Front Oncol 2021;11:7308242021-09-23 00:00:002021-09-23 00:00:00Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-26 / Biomedicines 2021 Aug;9(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-26 / Biomedicines 2021 Aug;9(9)2021-08-26 00:00:002021-08-26 00:00:00The Role of Curcumin in Cancer Treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-23 / Toxicol Appl Pharmacol 2021 Oct;429:115699
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-23 / Toxicol Appl Pharmacol 2021 Oct;429:1156992021-08-23 00:00:002021-08-23 00:00:00Targeting CD166 lung cancer stem cells: Molecular study using murine dendritic cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-20 / Front Immunol 2021;12:669965
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-20 / Front Immunol 2021;12:6699652021-08-20 00:00:002021-08-20 00:00:00Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-16 / Front Oncol 2021;11:675923
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-16 / Front Oncol 2021;11:6759232021-08-16 00:00:002021-08-16 00:00:00Curcumin as an Adjuvant to Cancer Immunotherapy
